SeaStar Medical (ICUCW) Stock: Why It's Up Today
Updated Oct 20, 2026, 4:00 PM ET Β· closing price
- Closed at $0.02, +0.50% vs the prior close of $0.02.
- Volume 2.76K shares, 17.1x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)
ICUCW rises 0.5% to $0.02 on 17.1x normal volume. Closed at $0.02, +0.50% vs the prior close of $0.02. Day range $0.02β$0.02, opened at $0.04.
ICUCW daily analysis β what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 β ICUCW rises 0.5% to $0.02 on 17.1x normal volume
- Closed at $0.02, +0.50% vs the prior close of $0.02. Day range $0.02β$0.02, opened at $0.04.
- Volume was 2.76K shares, 17.1x its 50-day average of 161 β unusually heavy trading.
- 52-week range $0.02β$0.02; today's close sits at 51% of that range, 19.0% below the 52-week high.
ICUCW bull case vs bear case (from the data)
- Annual revenue grew 814.1% in the latest fiscal year (SEC XBRL).
- Insiders made 12 open-market purchases in the last 12 months.
- Share count down 84.2% in a year (buybacks).
- Latest fiscal-year net income: loss of $12.15M.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
ICUCW latest news & SEC filings
Every SEC filing by or about ICUCW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
- Item 8.01 β Reported other events the company considers important.
Aug 19, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Messinger Michael bought 750 shares at $3.27 (β$2.45K) on Aug 18, 2026
- Messinger Michael bought 750 shares at $3.27 (β$2.45K) on Aug 18, 2026
- Messinger Michael bought 750 shares at $3.27 (β$2.45K) on Aug 18, 2026
- Messinger Michael bought 750 shares at $3.27 (β$2.45K) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 12, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $615.00K (prior year $338.00K) (+82.0% vs Jun 30, 2025)
- Net income: -$3.73M (prior year -$2.00M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.91 (prior year -$1.77) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 21, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Jun 23, 2026 Β· Form 8-K/A β Current report (amended)
Amended current report
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Things to know before you trade ICUCW
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 25, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.50% (largest 0.5%). That is a relatively calm stock.
- Liquidity: about 1.46K shares (β$29) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.02 vs a range of $0.02β$0.02 (51% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 0 sales; latest: Michael Messinger bought 750 shares on Aug 18, 2026.
- Latest filings: 8-K Oct 5, 2026; 10-Q Aug 12, 2026; 8-K Aug 12, 2026.
- Share count: 4.41M shares outstanding (Aug 5, 2026), -84.2% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
ICUCW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 0.04 | 0.02 | 0.02 | 0.02 | 2.76K |
| Oct 14, 2026 | 0.04 | 0.02 | 0.02 | 0.02 | 161 |
About SeaStar Medical
SeaStar Medical (ICUCW) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in DENVER, CO. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1831868.
ICUCW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jennifer A Baird | Director | Jul 2, 2026 |
| John Neuman | Director | Jul 2, 2026 |
| Heel Kenneth Van | Director | Jul 2, 2026 |
| Bernadette N Vincent | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kevin Chung | Chief Medical Officer | Jul 2, 2026 |
| Michael Messinger | Chief Financial Officer | Aug 19, 2026 |
| Eric Schlorff | Chief Executive Officer | Jul 2, 2026 |
| Bradford K Towne | Principal Accounting Officer | Feb 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Michael Messinger | Buy | 750 | $3.27 |
| Aug 18, 2026 | Michael Messinger | Buy | 750 | $3.27 |
| Aug 18, 2026 | Michael Messinger | Buy | 750 | $3.27 |
| Aug 18, 2026 | Michael Messinger | Buy | 750 | $3.27 |
| Dec 19, 2025 | Jennifer A Baird | Buy | 4,200 | $0.24 |
| Dec 19, 2025 | Jennifer A Baird | Buy | 4,200 | $0.24 |
| Dec 19, 2025 | Jennifer A Baird | Buy | 4,200 | $0.24 |
| Dec 19, 2025 | Jennifer A Baird | Buy | 4,200 | $0.24 |
| Dec 9, 2025 | Michael Messinger | Buy | 14,500 | $0.35 |
| Dec 9, 2025 | Michael Messinger | Buy | 14,500 | $0.35 |
| Dec 9, 2025 | Michael Messinger | Buy | 14,500 | $0.35 |
| Dec 9, 2025 | Michael Messinger | Buy | 14,500 | $0.35 |
ICUCW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.23M | $-12.15M | β | $-13.60M |
| Dec 31, 2024 | $135.00K | $-24.83M | -6.63 | $-16.01M |
| Dec 31, 2023 | $0 | $-26.23M | -30.26 | $-10.29M |
| Dec 31, 2022 | β | $-12.19M | -1.48 | $-7.79M |
| Dec 31, 2021 | β | $-4.60M | -0.63 | $-5.11M |
Latest balance sheet: total assets $8.65M, total liabilities $4.35M, cash $51.57K (as of Jun 30, 2026).
ICUCW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | β |
| May 13, 2026 | 8-K Item 2.02 (results) | β |
| Mar 25, 2026 | 8-K Item 2.02 (results) | β |
| Nov 13, 2025 | 8-K Item 2.02 (results) | β |
| May 14, 2025 | 8-K Item 2.02 (results) | β |
| Mar 27, 2025 | 8-K Item 2.02 (results) | β |
| Nov 13, 2024 | 8-K Item 2.02 (results) | β |
| May 14, 2024 | 8-K Item 2.02 (results) | β |
| Apr 17, 2024 | 8-K Item 2.02 (results) | β |
| Nov 22, 2023 | 8-K Item 2.02 (results) | β |
| Aug 15, 2023 | 8-K Item 2.02 (results) | β |
| May 16, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Dexcom (DXCM)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ICUCW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.